1 / 12

Interventional Cardiology Devices Market Research and Forecast Report 2023-2028

According to the latest research report by IMARC Group, The global interventional cardiology devices market size reached US$ 21.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.<br><br>More Info:- https://www.imarcgroup.com/interventional-cardiology-devices-market

Download Presentation

Interventional Cardiology Devices Market Research and Forecast Report 2023-2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Interventional Cardiology Devices Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

  2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

  3. Report Description and Highlights Report Description Global Interventional Cardiology Devices Market Research Report: The latest report by IMARC, titled “Interventional Cardiology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” " the global interventional cardiology devices market size reached US$ 21.3 Billion in 2022. Interventional cardiology devices refer to medical tools and equipment used to diagnose and treat cardiovascular diseases (CVDs). Some of the common devices include stents, mitral, catheters, angioplasty balloons, pulmonary and tricuspid valves, plaque modification, and hemodynamic flow alteration devices. These instruments are widely used for medical procedures, such as trans-myocardial laser revascularization (TMR), angioplasty, coronary artery bypass grafting (CABG), stenting, aneurysm repair, open-heart, off-pump heart, and minimally invasive (MI) heart surgeries. Interventional cardiology devices are less painful and cost-effective, require a shorter recovery period, suitable for infants and children, and reduce the risk of heart attacks. Request Free Sample Report: https://www.imarcgroup.com/interventional-cardiology-devices- market/requestsample

  4. Report Description and Highlights Report Description Global Interventional Cardiology Devices Market Trends: The rising geriatric population prone to chronic heart ailments across the globe is one of the key factors driving the market growth. Interventional cardiology devices are widely used to treat vascular and cardiovascular illnesses and capture embolic debris to ensure continuous blood flow and prevent blockages. In line with this, the increasing prevalence of CVDs on account of sedentary lifestyles and unhealthy dietary habits and patterns, such as smoking and alcohol consumption, is favoring the market growth. Additionally, the surging demand for compact cardiovascular devices, such as a balloon or stent, to open the obstructed artery, restore blood supply, and cause minimal scarring, is acting as another growth-inducing factor. Apart from this, the introduction of bioabsorbable and drug-eluting stents that help eliminate the chances of blood clots forming in a stent is providing an impetus to the market growth. Moreover, the widespread utilization of advanced imaging techniques, such as fractional flow reserve (FFR) and intravenous ultrasound (IVUS), for the early detection and prompt treatment of CVDs is positively influencing the market growth. Other factors, including rising expenditure capacities, significant growth in the healthcare industry, and shifting preferences toward MI procedures, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 33.8 Billion by 2028, exhibiting a CAGR of 7.5% during 2023-2028. Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

  5. Report Description and Highlights Report Description Market Summary: Breakup by Product: • Stents • Drug Eluting Stents • Bare Metal Stents • Bio-Absorbable Stents • Interventional Catheters • IVUS Catheters • Guiding Catheters • Angiography Catheters • PTCA Guidewires • Balloon Inflation Device • PTCA Balloons • Cutting Balloons • Scoring Balloons • Drug Eluting Balloons • Normal Balloons Breakup by End User:

  6. Report Description and Highlights Report Description • Hospitals • Ambulatory Surgical Centers • Others Breakup by Region: • North America • United States • Canada • Asia-Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Europe • Germany • France • United Kingdom

  7. Report Description and Highlights Report Description • Italy • Spain • Russia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa

  8. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • • • • Abbott Laboratories Alvimedica B. Braun Melsungen AG Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.) BIOTRONIK Inc. Boston Scientific Corporation Cook Group Incorporated ENDOCOR GmbH Koninklijke Philips N.V. Medinol Ltd. Medtronic plc Terumo Corporation. View Full Report with TOC & List of Figure: https://www.imarcgroup.com/interventional-cardiology- devices-market

  9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

  11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

  12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com

More Related